Publication | Closed Access
Coronary artery disease occurring with protease inhibitor therapy
35
Citations
0
References
1998
Year
Vascular DiseaseHyperlipidemiaCoronary Artery DiseaseAcute Myocardial InfarctionThrombosisMetabolic SyndromeTranslational MedicinePublic HealthHiv-1 Infected PatientsAtherosclerosisCardiologyDyslipidemiaLipid DisorderProtease InhibitorsVascular BiologyHivPharmacologyEpidemiologyProtease InhibitorCardiovascular DiseaseDiabetesProtease Inhibitor TherapyMedicine
Protease inhibitors are increasingly recognized as causing significant metabolic abnormalities including hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, diabetes, and lipodystrophy. Considerable concern has been generated by recent reports of premature coronary artery disease occurring in HIV-1 infected patients on protease inhibitor containing regimens.